Tele: 561.316.3330
Breaking Medical Device News

Monday, September 20, 2021

MEDICAL DEVICE NEWS MAGAZINE

A DIGITAL PUBLICATION FOR THE PRACTICING MEDICAL SPECIALIST, INDUSTRY EXECUTIVE AND INVESTOR
HomeNON PROFITCHA Hollywood Presbyterian Medical Center Opens First Dedicated Hospital-Based Ophthalmic Operating Room in Los Angeles County

CHA Hollywood Presbyterian Medical Center Opens First Dedicated Hospital-Based Ophthalmic Operating Room in Los Angeles County

Today CHA Hollywood Presbyterian Medical Center (CHA HPMC), a hospital that is a member of CHA Health Systems, a global network providing a full spectrum of dynamic healthcare services, announced the opening of a state-of-the-art ophthalmic surgery suite as part of the hospital’s Southern California Eye Institute. The new hospital-based ophthalmic operating room is the first hospital-based facility dedicated to eye surgery in the Los Angeles area.

Regarding the hospital-based ophthalmic operating room, Rohit Varma, MD, MPH, director of Southern California Eye Institute said, “As a team, we’ve taken bold steps to create a premier surgical suite that will offer the latest advancements and technology while focusing on patient experience and outcomes.”

The surgical suite is designed to create a seamless experience for patients and families. The operating rooms will be fully equipped with new state-of-the-art laser only cataract technology by early 2020, which will enable more precise intraocular implant measurements. The dedicated operating room will also have its own scheduling system, enabling convenient, faster scheduling for patients and community ophthalmologists.

“We’re very excited to finally have two ophthalmology-exclusive operating rooms available for patients and healthcare providers,” said Jacob Reznik, MD, a cataract and refractive surgery specialist who will oversee the surgery suite. “We will work closely with our colleagues and CHA HPMC physicians to continue building upon this center of excellence in ophthalmic surgery.”

With the laser-assisted cataract surgery technology, ophthalmic surgeons will be able to perform minimally invasive surgeries. New suite will also enable the performance of advanced glaucoma surgical tubes and trabeculectomies including XenGel implantation, microincisional glaucoma surgery including iStent, Hydrus, Kahook dual-blade (KDB) OMNI, and micropulse laser. Advanced retinal procedures will include small incision sutureless vitrectomy, epiretinal membrane surgery, and advanced diabetic disease procedures. Innovative oculofacial plastic surgery procedures will include ptosis (droopy eyelid), blepharoplasty (excess skin), ectropion (eyelid turning out), entropion (eyelid turning in), eyelid tumors, thyroid eye disease, tearing problems, facial trauma, and orbital tumors. The cutting edge therapy using the newest advanced technology will reduce surgical times and enable quick recovery for patients to return to their daily activities quickly.

“We are on a continual mission to create better ways — and embarked on a $400 million master plan slated for completion by 2021. We are making huge investments in the facility to develop Centers of Excellence, innovative technology, and people to better serve our Los Angeles community and be the medical center of the future,” said Robert Allen, CHA Hollywood Presbyterian Medical Center president and chief executive officer.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

Don't Miss

Mark Foster Joins Xenocor BOD

Foster is a versatile and visionary C-Suite executive who brings 20 years of general management and leadership experience from both venture-backed growth-stage organizations and world-class medical device companies

Hinge Health Acquires the Most Advanced Computer Vision Technology for Tracking Human Motion

CEO Daniel Perez explained, “We won’t stop investing in technology to deliver the most patient-centered digital clinic that improves member experience and outcomes while reducing costs. wrnch allows us to take a giant leap forward in all respects.”

Dale W Wood Congratulates the Huma Team on Raising $130 Million

Major health and technology companies across the world have committed upwards of $130 million to Huma Therapeutics, the health-tech company backed by Dale Ventures.

Rhaeos Awarded $4 Million NIH SBIR Grant

Under the NIH SBIR grant, Rhaeos will leverage their existing wireless sensor hardware to provide additional quantitative flow data to the clinician, giving insight into this currently inaccessible and highly relevant shunt performance metric.

Gynesonics Announces FDA Clearance of Next Generation Sonata System

“This clearance brings significant system improvements that expand the location of fibroids that can be treated while allowing the physician to control all aspects of the treatment from within the sterile field,” said Jiayu Chen, Ph.D. Vice President, Engineering and Advanced Technologies at Gynesonics.

Blackrock Neurotech Invests In Groundbreaking Auditory Nerve Implant With University Of Minnesota And MED-EL

The new investment will enable the development and translation of a new ANI through preclinical studies and later, a pilot clinical trial, where the ANI is then implanted in up to three deaf patients.

Jonathan Chapman: New President/CEO of Trividia Health

Chapman said, “I’m honored to join the Trividia team as President and CEO. This organization has a long history of leadership within the healthcare industry as a provider of accurate, accessible, and affordable point-of-care solutions for the management of diabetes.”

SOLOPASS® System (Bedside Neuro-Navigation Device) Receives FDA 510(k) Clearance

inTRAvent’s SOLOPASS® system brings simple, portable, bedside neuro-navigation into the intensive care unit.

By using this website you agree to accept Medical Device News Magazine Privacy Policy